Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
$10.96
+0.3%
$11.88
$4.88
$13.14
$1.60B1.052.06 million shs1.34 million shs
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
$0.29
+2.9%
$0.30
$0.23
$2.23
$9.33M0.6247,680 shs86,170 shs
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$1.00
-22.5%
$1.01
$0.71
$1.61
$80.77M1.19148,778 shs575,953 shs
iRadimed Corporation stock logo
IRMD
iRadimed
$61.54
+1.7%
$56.10
$42.34
$63.29
$769.39M0.9143,810 shs76,785 shs
SeaSpine Holdings Co. stock logo
SPNE
SeaSpine
$9.54
$8.53
$5.48
$14.23
$354.92M1.31822,700 shs1.16 million shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
+0.27%-2.49%-10.89%+7.35%+10.71%
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
+2.88%+3.51%+9.49%-11.46%-76.75%
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-22.48%-16.67%+16.55%+1.01%+21.68%
iRadimed Corporation stock logo
IRMD
iRadimed
+1.70%+1.89%+6.49%+19.82%+40.92%
SeaSpine Holdings Co. stock logo
SPNE
SeaSpine
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
4.2483 of 5 stars
3.41.00.03.32.74.20.6
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
4.4292 of 5 stars
3.55.00.04.41.60.01.3
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
1.795 of 5 stars
3.52.00.00.01.90.00.6
iRadimed Corporation stock logo
IRMD
iRadimed
4.691 of 5 stars
2.52.02.54.42.73.31.9
SeaSpine Holdings Co. stock logo
SPNE
SeaSpine
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
2.89
Moderate Buy$17.8963.22% Upside
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
3.00
Buy$5.501,823.08% Upside
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
3.00
Buy$5.50450.00% Upside
iRadimed Corporation stock logo
IRMD
iRadimed
3.00
Buy$72.0017.00% Upside
SeaSpine Holdings Co. stock logo
SPNE
SeaSpine
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest CTSO, IRMD, CODX, ATEC, and SPNE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/25/2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
6/16/2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeBuy$18.00
5/15/2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00 ➝ $10.00
5/15/2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$1.00 ➝ $1.00
5/2/2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$13.00 ➝ $15.00
5/2/2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$16.00 ➝ $16.00
5/2/2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00 ➝ $10.00
4/28/2025
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
D Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/28/2025
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$10.00
4/14/2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00 ➝ $20.00
4/3/2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$1.00 ➝ $1.00
(Data available from 7/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
$611.56M2.62N/AN/A($0.10) per share-109.60
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
$3.91M2.46N/AN/A$1.70 per share0.17
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$35.60M1.76N/AN/A$0.20 per share5.00
iRadimed Corporation stock logo
IRMD
iRadimed
$73.24M10.69$1.61 per share38.24$6.85 per share8.98
SeaSpine Holdings Co. stock logo
SPNE
SeaSpine
$191.45M1.85N/AN/A$8.57 per share1.11
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
-$162.12M-$1.15N/AN/AN/A-25.77%-1,657.19%-21.53%7/30/2025 (Estimated)
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
-$37.64M-$1.17N/AN/AN/A-1,025.45%-60.16%-52.69%8/6/2025 (Estimated)
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-$20.72M-$0.28N/AN/AN/A-41.77%-105.04%-29.18%8/12/2025 (Estimated)
iRadimed Corporation stock logo
IRMD
iRadimed
$19.23M$1.5539.7030.77N/A26.33%23.28%20.59%7/30/2025 (Estimated)
SeaSpine Holdings Co. stock logo
SPNE
SeaSpine
-$54.35M-$1.77N/AN/AN/A-28.22%-22.16%-17.09%N/A

Latest CTSO, IRMD, CODX, ATEC, and SPNE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2025Q2 2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
-$0.06N/AN/AN/A$178.85 millionN/A
5/14/2025Q1 2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-$0.08-$0.06+$0.02-$0.02$9.01 million$8.73 million
5/8/2025Q1 2025
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
-$0.33-$0.24+$0.09-$0.24$0.38 million$0.05 million
5/1/2025Q1 2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
-$0.12-$0.35-$0.23-$0.35$167.57 million$169.18 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
N/AN/AN/AN/AN/A
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
N/AN/AN/AN/AN/A
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
N/AN/AN/AN/AN/A
iRadimed Corporation stock logo
IRMD
iRadimed
$0.681.10%N/A43.87%1 Years
SeaSpine Holdings Co. stock logo
SPNE
SeaSpine
N/AN/AN/AN/AN/A

Latest CTSO, IRMD, CODX, ATEC, and SPNE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/5/2025
iRadimed Corporation stock logo
IRMD
iRadimed
quarterly$0.171.3%5/20/20255/20/20255/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
N/A
2.75
1.67
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
N/A
4.43
4.23
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
0.98
2.61
2.30
iRadimed Corporation stock logo
IRMD
iRadimed
N/A
8.87
7.62
SeaSpine Holdings Co. stock logo
SPNE
SeaSpine
0.09
3.18
1.65

Institutional Ownership

CompanyInstitutional Ownership
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
66.35%
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
14.99%
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
32.87%
iRadimed Corporation stock logo
IRMD
iRadimed
92.34%
SeaSpine Holdings Co. stock logo
SPNE
SeaSpine
70.81%

Insider Ownership

CompanyInsider Ownership
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
20.90%
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
8.40%
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
7.30%
iRadimed Corporation stock logo
IRMD
iRadimed
36.80%
SeaSpine Holdings Co. stock logo
SPNE
SeaSpine
9.32%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
700146.17 million115.62 millionOptionable
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
10033.57 million30.75 millionOptionable
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
22062.61 million58.04 millionOptionable
iRadimed Corporation stock logo
IRMD
iRadimed
11012.72 million8.04 millionOptionable
SeaSpine Holdings Co. stock logo
SPNE
SeaSpine
52337.20 million33.74 millionOptionable

Recent News About These Companies

Corewell Health adds 7D Flash
Orthofix faces class action suit for 'misleading investors'
Orthofix Shareholders Sue Over Misstatements on Fired Executives
Spine Biologics Market Size to Achieve USD 6.95 Bn by 2033
The 2024 Medtech Big 100: The world’s largest medical device companies
The Smartest Guys in Spine Are Buying ATEC Stock
Q2 2024 Orthofix Medical Inc Earnings Call

New MarketBeat Followers Over Time

Media Sentiment Over Time

Alphatec stock logo

Alphatec NASDAQ:ATEC

$10.96 +0.03 (+0.27%)
Closing price 07/2/2025 04:00 PM Eastern
Extended Trading
$10.93 -0.03 (-0.26%)
As of 05:29 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Co-Diagnostics stock logo

Co-Diagnostics NASDAQ:CODX

$0.29 +0.01 (+2.88%)
Closing price 07/2/2025 04:00 PM Eastern
Extended Trading
$0.30 +0.02 (+5.59%)
As of 05:33 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Cytosorbents stock logo

Cytosorbents NASDAQ:CTSO

$1.00 -0.29 (-22.48%)
Closing price 07/2/2025 04:00 PM Eastern
Extended Trading
$0.98 -0.02 (-1.50%)
As of 05:46 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.

iRadimed stock logo

iRadimed NASDAQ:IRMD

$61.54 +1.03 (+1.70%)
Closing price 07/2/2025 04:00 PM Eastern
Extended Trading
$61.54 0.00 (0.00%)
As of 07/2/2025 06:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

SeaSpine stock logo

SeaSpine NASDAQ:SPNE

As of January 4, 2023, SeaSpine Holdings Corporation was acquired by Orthofix Medical Inc. SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company's orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. It also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. In addition, the company offers implant products for spinal decompression, alignment, stabilization, and image-guided surgical solutions, as well as a surgical navigation system used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.